Literature DB >> 2927851

Logistic regression analysis of risk factors for intra-amniotic infection.

E R Newton1, T J Prihoda, R S Gibbs.   

Abstract

The identification of risk factors for intra-amniotic infection may allow changes in obstetric management and reduce complications. In a pilot study, stepwise logistic regression identified duration of ruptured membranes and duration of interval monitoring as significant risk factors for intra-amniotic infection. Using the preliminary regression equation, we established critical durations (risk criteria) to predict a 20% or greater probability of intra-amniotic infection. Subsequently, 2908 patients were screened prospectively for risk criteria and/or the presence of intra-amniotic infection. Seven hundred five patients of the 2908 (24%) met the risk criteria, and 107 of 124 cases of intra-amniotic infection (86%) met the risk criteria. In patients meeting the risk criteria, the relative risk of intra-amniotic infection was 19.7. In addition, 81 of 705 (12%) of mothers developed endometritis. Ten neonates of mothers with criteria developed sepsis or pneumonia. A stepwise logistic regression performed on the prospectively gathered data showed that among patients meeting risk criteria, parity, duration of internal monitoring, and duration of membrane rupture were the significant risk factors for intra-amniotic infection.

Entities:  

Mesh:

Year:  1989        PMID: 2927851

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

Review 1.  Perinatal bacterial infection: an update.

Authors:  T J Yeagley; J E Tolosa; V K Bhutani
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

2.  Maternal and fetal alternative complement pathway activation in early severe preeclampsia.

Authors:  M Camille Hoffman; Kristen K Rumer; Anita Kramer; Anne M Lynch; Virginia D Winn
Journal:  Am J Reprod Immunol       Date:  2013-10-16       Impact factor: 3.886

Review 3.  Diagnosis and management of clinical chorioamnionitis.

Authors:  Alan T N Tita; William W Andrews
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 4.  Amnioinfusion for chorioamnionitis.

Authors:  G Justus Hofmeyr; Joseph A K Kiiza
Journal:  Cochrane Database Syst Rev       Date:  2016-08-24

5.  Intrapartum fever, epidural analgesia and histologic chorioamnionitis.

Authors:  W M Curtin; P J Katzman; H Florescue; L A Metlay; S H Ural
Journal:  J Perinatol       Date:  2015-02-12       Impact factor: 2.521

Review 6.  Cortisol as a biomarker of stress in term human labor: physiological and methodological issues.

Authors:  Rebecca D Benfield; Edward R Newton; Charles J Tanner; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2013-01-21       Impact factor: 2.522

Review 7.  Premature rupture of membranes.

Authors:  P A Poma
Journal:  J Natl Med Assoc       Date:  1996-01       Impact factor: 1.798

8.  Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis.

Authors:  Celeste Beck; Kelly Gallagher; Leigh A Taylor; Jeffery A Goldstein; Leena B Mithal; Alison D Gernand
Journal:  Obstet Gynecol       Date:  2021-06-01       Impact factor: 7.623

9.  Clinical chorioamnionitis at term X: microbiology, clinical signs, placental pathology, and neonatal bacteremia - implications for clinical care.

Authors:  Roberto Romero; Percy Pacora; Juan Pedro Kusanovic; Eunjung Jung; Bogdan Panaitescu; Eli Maymon; Offer Erez; Susan Berman; David R Bryant; Nardhy Gomez-Lopez; Kevin R Theis; Gaurav Bhatti; Chong Jai Kim; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Lami Yeo; Ramiro Diaz-Primera; Julio Marin-Concha; Kia Lannaman; Ali Alhousseini; Hunter Gomez-Roberts; Aneesha Varrey; Angel Garcia-Sanchez; Maria Teresa Gervasi
Journal:  J Perinat Med       Date:  2021-01-26       Impact factor: 2.716

10.  Assessment of the value of routine blood cultures in the evaluation and treatment of patients with chorioamnionitis.

Authors:  G J Locksmith; P Duff
Journal:  Infect Dis Obstet Gynecol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.